RXRX
Recursion Pharmaceuticals Inc
3.80$
+8.2%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 2,677.3% | 1,855.2% | 91.0% | 121.7% | 97.1% | 76.9% | 162.0% | |
| -2,577.3% | 100.0% | 100.0% | -21.7% | 2.9% | 23.1% | -62.0% | |
| 2,677.3% | 1,855.2% | 1,352.7% | 392.4% | 549.8% | 534.4% | 569.4% | |
| 1,107.6% | 740.1% | 576.8% | 205.6% | 252.6% | 302.8% | 236.5% | |
| 3,749.4% | 2,579.2% | 1,927.8% | 597.6% | 800.8% | 837.2% | 805.9% | |
| -3,649.4% | -2,479.2% | -1,827.8% | -619.3% | -797.8% | -814.1% | -867.9% | |
| 37.1% | 39.8% | 29.5% | 0.1% | 0.2% | 2.7% | 2.4% | |
| -3,616.5% | -2,549.3% | -1,864.8% | -603.5% | -757.0% | -789.9% | -863.5% | |
| 37.8% | 25.7% | -84.1% | -0.1% | -9.3% | -1.9% | -0.2% | |
| -3,654.3% | -2,549.3% | -1,780.7% | -603.4% | -747.7% | -788.0% | -863.4% | |
| -3,409.5% | -2,393.9% | -1,743.7% | -589.6% | -701.1% | -725.2% | -749.0% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.